Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant CCI-779 in High-Risk Prostate Cancer
NCT00071968Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Aug 2003
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Aug 2003; status: completed.
02
Drugs
temsirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00071968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071968.